表紙
市場調査レポート

転移性脳腫瘍:世界の治験レビュー

Metastatic Brain Tumor Global Clinical Trials Review, H1, 2013

発行 GlobalData 商品コード 230803
出版日 ページ情報 英文 79 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
転移性脳腫瘍:世界の治験レビュー Metastatic Brain Tumor Global Clinical Trials Review, H1, 2013
出版日: 2013年02月28日 ページ情報: 英文 79 Pages
概要

当レポートでは、世界の転移性脳腫瘍治療薬の臨床試験について調査し、地域別の臨床市件数データ、試験段階、試験状況、採用テーマおよびスポンサー企業タイプ別の臨床試験データ、中断(一時中止、廃止、打ち切り)された試験のリストなどを提供しており、概略以下の構成でお届けします。

目次

  • イントロダクション
    • 転移性脳腫瘍
    • レポートガイダンス
  • 臨床試験:地域別
  • 臨床試験:国別
    • 臨床試験に寄与している上位国 − アジア太平洋地域
    • 臨床試験に寄与している上位5ヵ国 − 欧州
    • 臨床試験に寄与している上位国 − 北米
    • 臨床試験に寄与している上位国 − 中南米
  • 臨床試験 BRIC 諸国
  • 臨床試験 G7 諸国
  • 臨床試験 G7 諸国 , 治験ステータス別
  • 臨床試験 E7 諸国
  • 臨床試験 E7 諸国 , 治験ステータス別
  • 臨床試験:相別
    • 進行中の治験:相別
  • 臨床試験:治験ステータス別
  • 未完了の治験
  • 期間ごとの被験者数
  • 有力なスポンサー
  • 有望な治療薬比較
  • 臨床試験プロファイル
    • 臨床試験概要:上位企業
      • GlaxoSmithKline plc
    • 臨床試験概要:トップレベルの大学 / 研究機関 / 病院
      • Duke University
      • Case Comprehensive Cancer Center
      • The University of Utah
      • Wake Forest University
      • Masonic Cancer Center
      • Abramson Cancer Center
      • St. Mary's Hospital
      • Samsung Medical Center
      • University of Colorado
      • Yale University
      • Burzynski Research Institute, Inc.
      • Memorial Sloan Kettering Cancer Center
      • The University of Chicago
      • Federation Nationale des Centres de Lutte Contre le Cancer
      • Roswell Park Cancer Institute
      • Emory University
      • University of Medicine and Dentistry New Jersey
      • Massachusetts General Hospital
      • University of California, San Francisco
      • University Hospital, Bonn
  • 5件の主要な臨床プロファイル

付録

図表一覧


このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC1587CTIDB

Summary

GlobalData's clinical trial report, "Metastatic Brain Tumor Global Clinical Trials Review, H1, 2013" provides data on the Metastatic Brain Tumor clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Brain Tumor. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Brain Tumor. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Metastatic Brain Tumor
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Nations
  • Clinical Trials in G7 Nations by Trial Status
  • Clinical Trials by E7 Nations
  • Clinical Trials in E7 Nations by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Metastatic Brain Tumor
  • Subjects Recruited Over a Period of Time
  • Prominent Sponsors
    • Top Companies Participating in Metastatic Brain Tumor Therapeutics Clinical Trials
  • Prominent Drug Comparison
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Direct Therapeutics, Inc.
      • Clinical Trial Overview of Direct Therapeutics, Inc.
      • Burzynski Research Institute, Inc.
      • Clinical Trial Overview of Burzynski Research Institute, Inc.
      • Monteris Medical, Inc.
      • Clinical Trial Overview of Monteris Medical, Inc.
    • Clinical Trial Overview of Top Universities / Institutes / Hospitals
      • Case Comprehensive Cancer Center
      • Clinical Trial Overview of Case Comprehensive Cancer Center
      • Comprehensive Cancer Center of Wake Forest University
      • Clinical Trial Overview of Comprehensive Cancer Center of Wake Forest University
      • Abramson Cancer Center
      • Clinical Trial Overview of Abramson Cancer Center
      • St. Mary's Hospital
      • Clinical Trial Overview of St. Mary's Hospital
      • University College London
      • Clinical Trial Overview of University College London
      • Yale University
      • Clinical Trial Overview of Yale University
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • The University of Chicago
      • Clinical Trial Overview of The University of Chicago
      • University of Nebraska
      • Clinical Trial Overview of University of Nebraska
      • Federation Nationale des Centres de Lutte Contre le Cancer
      • Clinical Trial Overview of Federation Nationale des Centres de Lutte Contre le Cancer
      • Wake Forest University
      • Clinical Trial Overview of Wake Forest University
      • Samsung Medical Center
      • Clinical Trial Overview of Samsung Medical Center
      • University of Colorado
      • Clinical Trial Overview of University of Colorado
      • Thomas Jefferson University
      • Clinical Trial Overview of Thomas Jefferson University
      • Roswell Park Cancer Institute
      • Clinical Trial Overview of Roswell Park Cancer Institute
      • Emory University
      • Clinical Trial Overview of Emory University
      • University of Medicine and Dentistry New Jersey
      • Clinical Trial Overview of University of Medicine and Dentistry New Jersey
      • Duke University
      • Clinical Trial Overview of Duke University
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • University of California, San Francisco
      • Clinical Trial Overview of University of California, San Francisco
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials by Zone, 2013*
  • Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials by Top Countries, 2013*
  • Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials, Europe, Top Five Countries, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials, North America, Top Countries, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials, G7 Countries, 2013*
  • Metastatic Brain Tumor Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials, E7 Countries, 2013*
  • Metastatic Brain Tumor Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013*
  • Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials by Phase, 2013*
  • Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013*
  • Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials by Trial Status, 2013*
  • Metastatic Brain Tumor Therapeutics Market, Global, Terminated Clinical Trials, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
  • Metastatic Brain Tumor Therapeutics Clinical Trials, Global, Key Sponsors, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Direct Therapeutics, Inc., 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Burzynski Research Institute, Inc., 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Monteris Medical, Inc., 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Comprehensive Cancer Center of Wake Forest University, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Mary's Hospital, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by University College London, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Federation Nationale des Centres de Lutte Contre le Cancer, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2013*

List of Figures

  • Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials by Zone (%), 2013*
  • Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials by Top Countries, 2013*
  • Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials, North America, Top Countries (%), 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials, G7 Countries (%), 2013*
  • Metastatic Brain Tumor Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013*
  • Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials by Phase (%), 2013*
  • Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013*
  • Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials by Trial Status, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
  • Metastatic Brain Tumor Therapeutics Clinical Trials, Global, Key Sponsors, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013*
  • Metastatic Brain Tumor Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013*
  • GlobalData Methodology
Back to Top